2m 2m 2m 2m 2m 2m 2m
Theralink Tech (THER)
OTC
$0.000001$0.00 (0.00%)
Price as of Jul 16, 2026- $6,151.00Market Cap
- -99.00%1-Year Change
- BiotechnologyIndustry
Theralink Tech (THER)
$0.000001$0.00 (0.00%)
Annual
Quarterly
09/30/2023 | 09/30/2022 | 09/30/2021 | 09/30/2020 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 606,796 +6.85% | 567,905 +12.32% | 505,604 +178.99% | 181,229 N/A | |
Cost of Revenue | 126,237 -43.87% | 224,886 +91.46% | 117,456 +123.36% | 52,587 N/A | |
Gross Profit | 480,559 +40.10% | 343,019 -11.63% | 388,148 +201.73% | 128,642 N/A | |
Sales and Marketing Expense | 125,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | -150,000 N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 208,287 +9.18% | 190,780 +2.72% | 185,730 +89.98% | 97,761 N/A | |
Total Operating Expenses | 9.5M -21.06% | 12.0M +101.26% | 6.0M +70.83% | 3.5M N/A | |
Operating Profit | -9.0M -22.86% | -11.6M +109.13% | -5.6M +65.81% | -3.4M N/A | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | 10,000 N/A | |
Interest Expense | -16.9M +1,444.47% | -1.1M +803.97% | -121,094 +287.90% | -31,218 N/A | |
Interest Income and Expense and Net | -16.9M +1,444.47% | -1.1M +803.97% | -121,094 +470.71% | -21,218 N/A | |
Total Nonoperating Income and Expense | -21.9M +1,889.93% | -1.1M -1,268.19% | 94,330 -49.43% | 186,523 N/A | |
Income before Taxes | -30.9M +138.38% | -13.0M +95.56% | -6.6M +28.24% | -5.2M N/A | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | 238,671 N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -30.9M +142.56% | -12.7M +132.87% | -5.5M +72.59% | -3.2M N/A | |
Net Income from Continuing Operations Applicable to Common | -30.9M +138.38% | -13.0M +95.56% | -6.6M +28.24% | -5.2M N/A | |
Basic EPS and Net Income | -0.01 N/A | 0.00 N/A | 0.00 +100.00% | -0.06 N/A | |
Diluted EPS and Net Income | -0.01 N/A | 0.00 N/A | 0.00 +100.00% | -0.06 N/A | |
Basic Weighted Average Shares | 6.2B +4.60% | 5.9B +9.53% | 5.4B +6,242.72% | 84.7M N/A | |
Diluted Weighted Average Shares | 6.2B +4.60% | 5.9B +9.53% | 5.4B +6,242.72% | 84.7M N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 997,484 +153.52% | 393,460 +25.25% | 314,151 -82.34% | 1.8M N/A | |
Short-Term Investments | 800 -78.38% | 3,700 -66.36% | 11,000 -0.90% | 11,100 N/A | |
Cash and Cash Equivalents and Short-Term Investments | 998,284 +151.36% | 397,160 +22.15% | 325,151 -81.84% | 1.8M N/A | |
Total Current Assets | 1.3M +95.17% | 646,984 +1.29% | 638,753 -69.11% | 2.1M N/A | |
Accumulated Depreciation | 520,135 +45.36% | 357,815 +67.67% | 213,404 +188.22% | 74,042 N/A | |
Property and Plant and Equipment and Net | 448,515 -34.63% | 686,127 -1.83% | 698,927 -6.16% | 744,822 N/A | |
Total Long-Term Assets | 448,515 -37.13% | 713,397 +2.07% | 698,927 -6.16% | 744,822 N/A | |
Total Assets | 2.8M +9.65% | 2.6M +58.61% | 1.6M -48.73% | 3.2M N/A | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 18.6M +5,190.45% | 351,000 +247.52% | 101,000 +10,000.00% | 1,000 N/A | |
Total Current Liabilities | 39.8M +1,052.72% | 3.5M +4.84% | 3.3M +176.81% | 1.2M N/A | |
Total Long-Term Debt | 26.0M +5,733.11% | 446,281 +586.79% | 64,981 -87.93% | 538,496 N/A | |
Total Long-Term Liabilities | 1.1M -2.71% | 1.2M +760.90% | 134,482 -23.98% | 176,893 N/A | |
Total Liabilities | 41.0M +540.09% | 6.4M +78.57% | 3.6M +138.33% | 1.5M N/A | |
Retained Earnings | -93.8M +49.27% | -62.8M +26.05% | -49.8M +15.37% | -43.2M N/A | |
Total Stockholders Equity | -38.1M +460.44% | -6.8M +37.52% | -4.9M +1,507.75% | -307,595 N/A | |
Total Shares Outstanding | 6.2B 0.00% | 6.2B +20.05% | 5.1B 0.00% | 5.1B N/A | |
Cash Flow | |||||
Cash from Operating Activities | -5.8M +7.15% | -5.4M +12.73% | -4.8M +37.75% | -3.5M N/A | |
Capital Expenditures | 163,380 +24.14% | 131,611 -3.01% | 135,702 -74.47% | 531,538 N/A | |
Cash from Investing Activities | -163,380 +24.14% | -131,611 -1.93% | -134,202 -192.94% | 144,390 N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 6.5M +16.81% | 5.6M +62.34% | 3.5M -24.10% | 4.5M N/A | |
Financials Ratio | |||||
Gross Margin | 79.20% +31.12% | 60.40% -21.32% | 76.77% +8.15% | 70.98% N/A | |
Operating Margin | -1,479.80% -27.80% | -2,049.64% +86.19% | -1,100.86% -40.57% | -1,852.24% N/A | |
Return on Assets | -1,134.49% +88.64% | -601.39% +165.69% | -226.35% +17.46% | -192.70% N/A | |
Return on Equity | 137.62% -36.57% | 216.95% +4.14% | 208.33% +433.75% | 39.03% N/A | |
Revenue Growth | 6.85% -44.42% | 12.32% -93.12% | 178.99% N/A | N/A N/A | |
Current Ratio | 0.03 -83.07% | 0.19 -3.41% | 0.19 -88.84% | 1.74 N/A | |
Cash Ratio | 0.03 -78.05% | 0.11 +19.52% | 0.10 -93.62% | 1.49 N/A | |
Debt-to-Equity Ratio | -1.17 +898.46% | -0.12 +248.81% | -0.03 -98.08% | -1.75 N/A | |
Debt-to-Assets Ratio | 15.65 +5,001.30% | 0.31 +202.86% | 0.10 -39.99% | 0.17 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow